Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
about
Biomarkers of Alzheimer's diseaseDefault-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRIPattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.Diagnostic imaging devices in Alzheimer's disease.Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imagingExamining the multifactorial nature of cognitive aging with covariance analysis of positron emission tomography dataOptimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer diseaseExpression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit.Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.Which language declines more? longitudinal versus cross-sectional decline of picture naming in bilinguals with Alzheimer's disease.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoEmerging biomarkers in cognition.Biomarkers in Alzheimer's disease.The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test.Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.Longitudinal brain activity changes in asymptomatic Alzheimer diseaseSingle photon emission computed tomography perfusion differences in mild cognitive impairment.Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.Cerebral blood flow in Alzheimer's diseaseHypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaintsTau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathyGraded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorderElevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment.Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's diseaseMRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.Imaging cerebral blood flow in the cognitively normal aging brain with arterial spin labeling: implications for imaging of neurodegenerative disease.FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's diseasePattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience.Sensory evoked and event related oscillations in Alzheimer's disease: a short review.The effect of exercise on behavioral and psychological symptoms of dementia: towards a research agenda.Multisensory integration mechanisms during aging.The role of cholesterol metabolism in Alzheimer's disease.TMS as a Tool for Examining Cognitive Processing.Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.Regional cerebral perfusion differences between periventricular grey, thalamic and dual target deep brain stimulation for chronic neuropathic pain.Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion.
P2860
Q24650667-32E405D7-84CB-4B67-ABD5-64EC08643EB0Q29619152-B7C02EAB-B73C-4196-BA8E-9C1C405AB5B8Q30983673-2F746F09-B958-4B82-B504-542E714C8116Q30989943-6EC2C24C-B331-41E0-9E1C-8331BEA01210Q31117394-686F9B35-95A6-4CB8-9525-A575C36FC46AQ33402373-7AA40951-4ED5-4999-9E3A-0BCEBF321BDBQ33497053-397546B3-3133-4402-A35A-628C5C801DA7Q33632112-CB22B9DB-255C-45DF-BC16-BBB7A5EE58AFQ33721909-2916D9B2-F8B1-404D-85B0-D16EA78A6084Q33819121-BACE9F68-241E-4A5D-9778-F9ED3A999D69Q34116029-3A30B396-303C-4967-B21D-F2357580898DQ34407237-927140B1-C84D-447E-9CF3-3A386A38F13FQ34639246-913FEA67-19C4-4417-B1D5-5504FEE39710Q35008258-6006AA82-B789-4A3A-9B62-4084674C6220Q35113795-409EB63A-2D74-495B-9554-E4D1F9A1EA5BQ35485920-8A987675-DAC9-43B4-AA16-5239369D8162Q35852208-50690187-BD26-482F-9467-E29E25E66FAEQ36053899-2E00120A-2720-4EC3-8924-2D181BDF996FQ36226953-CFB030B8-C75F-42E1-922B-53BFDBE0E28FQ36341967-CECD9F9E-E5CF-4ACD-8D1B-CBBD9B320A4CQ36349775-138CB436-214E-4A0B-9E5A-8CC15DBEC644Q36661066-6F0BD67A-880D-47CD-A83F-0F36E8DC968BQ36809375-F850EDCF-8D2C-4DD8-BBB4-8EDAC6B669D3Q36869854-8B2514C9-38DC-4955-9D6D-B17CD2CA91CFQ36985886-B8CDF084-FC98-46DC-A689-6F77D3B68875Q37019704-A789D67C-0E6B-40EA-A7EE-D6446896A92DQ37064559-ECC13700-164A-4BBE-ADCE-0A5C18DC569CQ37141206-EEC9D7AF-FBE7-4DAF-9297-D7F9ED32542DQ37178967-95FF203D-1A1C-4A4C-AD5A-6100C582E95EQ37371507-D2EFF6BE-55A9-49FE-9E74-4C12DF33B90AQ37415324-E6F23CAA-FB6F-4F80-BECB-F8B9069EDE41Q37677982-4601E5B1-A5A4-4955-BBF0-705F73AFBF77Q37963384-39F590F1-16B8-421F-86C6-09C5B88BB653Q37968708-1DA0550F-173F-41D0-8E0C-38BB909DB9AAQ38174874-C226BF27-7DAC-413C-A4DD-5E952EED9EE7Q38212604-F339B85E-DEF7-4575-A448-22908211F14CQ38532565-5ACBE4DB-5DF4-485F-8014-5A271B215C73Q38960655-417AD85E-D282-4203-AE4F-330E0567F87EQ39337760-A6992B03-F7EA-4B68-94CF-03C57F2566E2Q40183680-EDD8ADE2-0B10-46EC-ACC8-FBAC4E036AF6
P2860
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@en
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@nl
type
label
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@en
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@nl
prefLabel
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@en
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
@en
P2093
B J Shepstone
E M-F King
K M Bradley
N D W Soper
V T O'Sullivan
P304
P356
10.1093/BRAIN/AWF185
P407
P577
2002-08-01T00:00:00Z